“Block Chain Drug Tracking Solution”

The company announced that it has launched the JD Medicine Open Tracking Solution based on block-chain technology to provide pharmaceutical supply chain transparency in the Chinese market.

The solution, announced during the Big Data Summit in Beijing, China, is available from the JD Blockchain Open Platform. It is intended to provide transparent information to dispel concerns about the authenticity of medicines. It includes all stages of production, transportation, storage, and sales, as well as improved data collection efficiency by utilizing the user interface and the Internet.

The reason for this solution is due to the recent accident in the Chinese market. Concerns about the safety and source of the drug in China have been growing since the expiration date or the use of an under-safety vaccine.

“Public traceability solutions will provide the transparency and accountability needed by consumers, businesses, governments, and the pharmaceutical industry,” said Pane Ahn, general manager of Big Data Smart Supply Chain. “We will make every effort to utilize our technology capabilities to accurately collect information.” has been trying to provide a block chain function by showing the open platform of the ching block chain earlier this year. As part of the Retail as a Service (RaaS) strategy, we are strengthening our partner capabilities by leveraging our supply chain, technology and logistics strengths. According to, China Pacific Insurance Corporation has been using this platform to build a Papiao traceable system, an official receipt for business in China.



Through the monthly AHC PC and HowPC magazine era, he has watched 'technology age' in online IT media such as ZDNet, electronic newspaper Internet manager, editor of Consumer Journal Ivers, TechHolic publisher, and editor of Venture Square. I am curious about this market that is still full of vitality.

Add comment

Follow us

Don't be shy, get in touch. We love meeting interesting people and making new friends.

Most discussed